A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P11187
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs P 11187 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- Sponsors Piramal Enterprises
- 27 Aug 2014 Last checked against the ClinicalTrials.gov record, planned end date changed from 1 Jan 2015 to 1 Dec 2015.
- 29 Jun 2013 New trial record
- 01 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.